Pfizer stock price, PFE

Pfizer stock chart:



Pfizer close price: 34

Stock price forecast:

DOWN TO -2.00%
Target: 33.32

Total forecasts: 90
Reached: 39 (43.33%)

Total Win: 18.40 (57.10%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90914043.96%19.220.66%1,713.46-20.54-1.20%-1.32-0.04%
303100.00%0.000.00%1,061.697.690.72%7.690.72%
141500.00%0.000.00%514.074.070.79%4.070.79%
7800.00%0.000.00%274.352.350.86%2.350.86%

Showing 1-10 of 530 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-03-253433.310000-00-00
2017-03-2434.2933.440000-00-00
2017-03-2334.4733.480000-00-00
2017-03-2234.2533.290000-00-00
2017-03-2134.3833.360000-00-00
2017-03-2034.3233.550000-00-00
2017-03-1934.3233.470000-00-00
2017-03-1834.3233.450000-00-00
2017-03-1734.4333.480000-00-00
2017-03-1634.6333.540000-00-00

Pfizer latest news:


  • 02/17/2017 16:41:03

    Momenta Pharma shares halted as drug application hits speed bump

    Momenta Pharmaceuticals Inc. were halted in the extended session Friday after the biotech company said a supplier's compliance issue could delay approval of a higher dose of one of its multiple sclerosis drugs. Momenta shares were halted at $19 after hours. The company said a key supplier of its Glatopa multiple sclerosis drug, Pfizer Inc. , was served with a Food and Drug Administration Warning Letter, meaning something at the Pfizer facility was not in compliance with FDA code. Until the facility demonstrates compliance, Momenta said that approval for its marketing application for a 40 mg. dose of Glatopa is "unlikely" in the first quarter. Pfizer shares declined 0.4% to $33.48 after hours.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 01/31/2017 13:01:32

    Pfizer Swings to 4Q Profit After Rough Year, Hikes 2017 View

    Drugmaker Pfizer Inc. is forecasting slightly higher sales and profit this year after a difficult 2016, though reduced spending on overhead and lawsuits helped it swing to a fourth-quarter profit, following a loss a year earlier

  • 01/31/2017 06:16:00

    Pfizer 4Q Profit Misses Estimates

    Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

  • More trends:

    Pharmerica CorporationPMC | PHH CorpPHH | Philip Morris International IncPM | Philippine Long Distance Telephone CompanyPHI | Phillips 66PSX+5.71% | Phillips 66 Partners LPPSXP | Phoenix CompaniesPFX | Phoenix CompaniesPNX | Phoenix New Media LimitedFENG | Physicians Realty TrustDOC |